Concourse Financial Group Securities’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 4552 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5624 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5612 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5641 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5648 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5589 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5486 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5375 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5190 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5176 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4988 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5007 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4914 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4943 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4817 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4669 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4545 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4429 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4248 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4135 |
|